Decoy Therapeutics (DCOY) Operating Expenses (2015 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Operating Expenses of $2.3 million for Q1 2026, up 32.88% year-over-year from $1.7 million in Q1 2025, and down 74.72% quarter-over-quarter from $9.0 million in Q4 2025.
Decoy Therapeutics (DCOY) Operating Expenses (2015 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Operating Expenses for 12 consecutive years, with $2.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 32.88% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $13.2 million (up 131.97% YoY), while the FY2025 annual figure was $12.6 million, up 119.97% from the prior year.
- Operating Expenses retreated to $2.3 million in Q1 2026 per DCOY's latest filing, from $9.0 million in the prior quarter.
- Across five years, Operating Expenses topped out at $14.5 million in Q3 2022 and bottomed at $895130.0 in Q3 2025.
- Historically, Operating Expenses has averaged $3.8 million across 5 years, with a median of $2.3 million in 2026.
- Annual changes were most pronounced in 2023 — Operating Expenses plunged 85.02% — and 2025, when it jumped 506.87%.
- Decoy Therapeutics' Operating Expenses stood at $6.5 million in 2022, then slumped by 85.02% to $970701.0 in 2023, then soared by 53.36% to $1.5 million in 2024, then surged by 506.87% to $9.0 million in 2025, then plunged by 74.72% to $2.3 million in 2026.
- Business Quant data shows DCOY's Operating Expenses at $2.3 million in Q1 2026, $9.0 million in Q4 2025, and $895130.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Decoy Therapeutics | 1.82 Mn | 1.82 Mn | - | 2.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.63 Mn |
| Mar 31, 2026 | 2.28 Mn |
| Dec 31, 2025 | 9.03 Mn |
| Sep 30, 2025 | 895,130.00 |
| Jun 30, 2025 | 965,565.00 |
| Mar 31, 2025 | 1.72 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 1.77 Mn |
| Dec 31, 2023 | 970,701.00 |
| Sep 30, 2023 | 2.53 Mn |
| Jun 30, 2023 | 3.97 Mn |
| Mar 31, 2023 | 5.42 Mn |
| Dec 31, 2022 | 6.48 Mn |
| Sep 30, 2022 | 14.49 Mn |
| Jun 30, 2022 | 4.76 Mn |
| Mar 31, 2022 | 6.12 Mn |
| Dec 31, 2021 | 4.14 Mn |
| Sep 30, 2021 | 3.75 Mn |